CN1259912C - 用于治疗升高的血压的西酞普兰 - Google Patents

用于治疗升高的血压的西酞普兰 Download PDF

Info

Publication number
CN1259912C
CN1259912C CNB038012936A CN03801293A CN1259912C CN 1259912 C CN1259912 C CN 1259912C CN B038012936 A CNB038012936 A CN B038012936A CN 03801293 A CN03801293 A CN 03801293A CN 1259912 C CN1259912 C CN 1259912C
Authority
CN
China
Prior art keywords
blood pressure
citalopram
application
patients
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038012936A
Other languages
English (en)
Chinese (zh)
Other versions
CN1568183A (zh
Inventor
P·S·加博尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Publication of CN1568183A publication Critical patent/CN1568183A/zh
Application granted granted Critical
Publication of CN1259912C publication Critical patent/CN1259912C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
CNB038012936A 2002-03-14 2003-03-13 用于治疗升高的血压的西酞普兰 Expired - Fee Related CN1259912C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP0200980 2002-03-14
HU0200980A HU0200980D0 (enExample) 2002-03-14 2002-03-14

Publications (2)

Publication Number Publication Date
CN1568183A CN1568183A (zh) 2005-01-19
CN1259912C true CN1259912C (zh) 2006-06-21

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038012936A Expired - Fee Related CN1259912C (zh) 2002-03-14 2003-03-13 用于治疗升高的血压的西酞普兰

Country Status (34)

Country Link
US (1) US7141604B2 (enExample)
EP (1) EP1490049B1 (enExample)
JP (1) JP2005519945A (enExample)
KR (1) KR100718368B1 (enExample)
CN (1) CN1259912C (enExample)
AT (1) ATE324887T1 (enExample)
AU (1) AU2003211195B2 (enExample)
BG (1) BG108904A (enExample)
BR (1) BR0303384A (enExample)
CA (1) CA2459834A1 (enExample)
CY (1) CY1106129T1 (enExample)
CZ (1) CZ2004661A3 (enExample)
DE (1) DE60305018T2 (enExample)
DK (1) DK1490049T3 (enExample)
EA (1) EA008350B1 (enExample)
EE (1) EE200400069A (enExample)
ES (2) ES2263009T3 (enExample)
HR (1) HRP20040165B1 (enExample)
HU (1) HU0200980D0 (enExample)
IL (2) IL160486A0 (enExample)
IS (1) IS2392B (enExample)
LT (1) LT5255B (enExample)
LV (1) LV13281B (enExample)
MX (1) MXPA04008919A (enExample)
NO (1) NO20034998D0 (enExample)
PL (1) PL368902A1 (enExample)
PT (1) PT1490049E (enExample)
SI (1) SI1490049T1 (enExample)
SK (1) SK2222004A3 (enExample)
TR (1) TR200401036T1 (enExample)
UA (1) UA77506C2 (enExample)
WO (1) WO2003075914A1 (enExample)
YU (1) YU91203A (enExample)
ZA (1) ZA200408056B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1673107T3 (pl) * 2003-10-10 2008-06-30 Abbott Laboratories Gmbh Kompozycja farmaceutyczna zawierająca selektywnego agonistę receptora imidazoliny I1 i bloker receptora angiotensyny II
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
DK1015416T3 (da) * 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
JP3813820B2 (ja) * 1997-11-11 2006-08-23 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
IL160486A0 (en) 2004-07-25
SK2222004A3 (en) 2004-08-03
KR100718368B1 (ko) 2007-05-14
ES2238939A1 (es) 2005-09-01
ZA200408056B (en) 2005-10-10
DK1490049T3 (da) 2006-08-21
ES2263009T3 (es) 2006-12-01
IS7418A (is) 2004-08-20
BR0303384A (pt) 2004-03-30
CY1106129T1 (el) 2011-06-08
ATE324887T1 (de) 2006-06-15
CZ2004661A3 (cs) 2004-10-13
LT5255B (lt) 2005-08-25
YU91203A (sh) 2006-08-17
CN1568183A (zh) 2005-01-19
PL368902A1 (en) 2005-04-04
EP1490049B1 (en) 2006-05-03
LV13281B (en) 2005-09-20
AU2003211195A2 (en) 2003-09-22
SI1490049T1 (sl) 2006-10-31
JP2005519945A (ja) 2005-07-07
PT1490049E (pt) 2006-08-31
EA200401147A1 (ru) 2005-02-24
HRP20040165A2 (en) 2004-10-31
EE200400069A (et) 2004-08-16
HK1075390A1 (en) 2005-12-16
AU2003211195A1 (en) 2003-09-22
US20050065209A1 (en) 2005-03-24
HU0200980D0 (enExample) 2002-05-29
HRP20040165B1 (hr) 2007-08-31
ES2238939B2 (es) 2006-04-16
EA008350B1 (ru) 2007-04-27
CA2459834A1 (en) 2003-09-18
WO2003075914A1 (en) 2003-09-18
DE60305018T2 (de) 2006-11-30
MXPA04008919A (es) 2004-11-26
IS2392B (is) 2008-08-15
UA77506C2 (en) 2006-12-15
EP1490049A1 (en) 2004-12-29
IL160486A (en) 2008-06-05
NO20034998D0 (no) 2003-11-10
DE60305018D1 (de) 2006-06-08
TR200401036T1 (tr) 2005-10-21
LT2004049A (en) 2005-03-25
BG108904A (en) 2006-04-28
AU2003211195B2 (en) 2007-10-18
US7141604B2 (en) 2006-11-28
KR20040090949A (ko) 2004-10-27

Similar Documents

Publication Publication Date Title
CN1084618C (zh) 5-羟色胺拮抗剂的新应用
JP6257641B2 (ja) ボルチオキセチンとドネペジルとを含む組成物
EP2305226A1 (en) Combination therapy for the treatment of sleep apnea
AU2022241499A1 (en) S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
CN1259912C (zh) 用于治疗升高的血压的西酞普兰
CN1250218C (zh) 血管紧张素拮ⅱ抗剂的新用途
TW200846002A (en) Novel prophylactic and/or therapeutic agent for diabetic neuropathy
CN1298389C (zh) 一种含替米沙坦和钙离子拮抗剂的复方降压制剂及其应用
HK1075390B (en) Citalopram for the treatment of elevated blood pressure
CN1671368A (zh) 疼痛继发性抑郁(dsp)的治疗
HK1014861A1 (en) Use of carbazole compounds in the manufacture of a medicament for the treatment of congestive heart failure
HK1014861B (en) Use of carbazole compounds in the manufacture of a medicament for the treatment of congestive heart failure
CN1914194A (zh) 用于伴随旁路术的血管痉挛的治疗剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060621